Oral supplementation of L-arginine prevents chronic cyclosporine nephrotoxicity in rats

Experimental Nephrology

Volumn 6, Issue 1, 1998, Pages 50-56

  Yang, Chul Woo ^a   Kim, Yong Soo ^a   Kim, Jin ^a   Kim, Young Ok ^a   Min, So Youn ^a   Choi, Euy Jin ^a   Bang, Byung Kee ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Cyclosporine; L Arginine; N Nitro L arginine methyl ester; Nitric oxide; Plasma renin activity

Indexed keywords

ARGININE; CYCLOSPORIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG SCREENING; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; KIDNEY FIBROSIS; MALE; NEPHROTOXICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PATHOGENESIS; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RAT; SODIUM RESTRICTION;

EID: 6844250115     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: 10.1159/000020504     Document Type: Article

References (58)

1. Benaett WM: The nephrotoxicity of immunosuppressive drugs. Clin Nephrol 1995;43 (suppl):3-7.
2. Versluis DJ, Ten Kate FJ, Wenting GJ, Jeekel J, Weimar W: Histological lessons associated with cyclosporine: Incidence and reversibility in one year old kidney transplants. J Clin Pathol 1988;41:498-503.
3. Myers BD, Sibley L, Newton L, Tomlanovich SJ, Boshkos C. Slinson E, Leutscher JA, Whitney DJ. Krasm D, Coplon NS, et al: The longterm course of cyclosponne-associated chronic nephropathy. Kidney Int 1988;33:590-600.
4. Baylis C, Harton P, Engels K: Endothelial denved relaxing factor controls renal hemodynamics in the normal rat kidney J Am Soc Nephrol 1990;1:875-881.
5. Kon V, Sugiura M, Inagami T. Harne BR, Ichikawa I, Hoover RL: Role of endothelin in cyclosporine-mduced glomerular dysfunction. Kidney Int 1990;37:1487-1491.
6. Benigni A, Chiabrando C, Piccinelli A, Perico N, Gavinelli M, Furci L, Patino O, Abbate M, Bertani T, Remuzzi G: Increased urinary excretion of thromboxane B2 and 2,3-dinor-TxB2 in cyclosporine A nephrotoxicity. Kidney Int 1988;34:164-174.
7. Penco N, Benigrsi A, Bosco E, Rossini M, Onsio S, Ghilardi F, Piccinelli A, Remuzzi G: Acute cyclosporine A nephrotoxicity in rats: Which role for renin-angiotensin system and glomerular prostaglandins? Clin Nephrol 1985; 25(suppl l):83-88.
8. Gerkens JF: Cyclosponne treatment of normal rats produces a rise in blood pressure and decreased renal vascular responses to nerve stimulation, vasoconstnctors and endothelialdependent dilators, J Pharmacol Exp Ther 1989;250:1105-1112.
9. 2-. Circ Res 1994; 74:477-484.
10. Ribeiro MO, Antunes E, de Nucci G, Lovisolo SM, Zatz R: Chronic inhibition of nitric oxide synthesis: A new model of arterial hypertension. Hypertension 1992;20:298-303.
11. G-nitro-L-arginme-methyl ester on renal function and blood pressure. Am J Physiol 1991;261: F1033-F1037.
12. De Nicola L, Thomson SC, Wead LM, Brown MR, Gabbai FB: Argmine feeding modifies cyclosponne nephrotoxicity in rats. J Clin Invest 1993;92:1859-1865.
13. Lafayette RA, Meyer G, Meyer TW: The effects of blood pressure reduction on cyclosponne nephrotoxicity in the rat. J Am Soc Nepbrol 1993;3:1892-1899.
14. Rosen S. Greenfeld Z, Brezis M: Chronic cyclosporine-induced nephropathy in the rat. A medullan ray and inner stripe injury Transplantation 1990;42:445-452.
15. Elzinga LW. Rosen S, Bennett WM: Dissociation of glomerular filtration rate from tubulointerstitial fibrosis in experimental chronic cyclosporine nephropathy: Role of sodium intake. J Am Soc Nephrol 1993;4:214-221.
16. Reyes AA, Purkerson ML, Karl I. Klahr S: Dietary supplementation with L-arginme ameliorates the progression of renal disease in rats with subtotal nephrectomy. Am J Kidney Dis 1992;20:168-176.
17. Ashab I. Peer G, Blum M, Wollman Y, Chernihovsky T, Hassner A, Schwartz D, Cabili S, Silverberg D, Laina A: Oral administration of L-arginine and captopril in rats prevents chronic renal failure by nitric oxide production. Kidney Int 1995;47:1515-1521.
18. Jobin J, Bonjour JP: Measurement of glomerular filtration rate in conscious unrestrained rats with inulin infused by implanted osmotic pumps. Am J Physiol 1985;248:F734-F738.
19. Bartholomew B: A rapid method for the assay of nitrate in urine using the nitrate reductase enzyme of Escherichia coli. Chem Toxicol 1984;22:541-543.
20. Gallego MJ, Lopez Farre A, Riesco A, Monton M, Grandes SM, Barat A, Hernando L, Casado S, Caramelo CA: Blockade of endotheliumdependent responses in conscious rats by cyclosporine A: Effect of L-arginine. Am J Physiol 1993;264:H708-H714.
21. Andoh TF, Burdmann EA, Fransechini N, Houghton DC, Bennett WM: Comparison of acute rapamycin nephrotoxicity with cyclosponne and FK506. Kidney Int 1996;50:1110-1117.
22. Gardner MP, Houghton DC, Andoh TF, Lindsley J, Bennett WM: Clinically relevant doses and blood levels produce experimental cyclosporine nephrotoxicity when combined with nitric oxide inhibition. Transplantation 1996;61:1506-1512.
23. Diedench D, Yang Z, Luscher TF: Chronic cyclosporine therapy impairs endothelium-dependent relaxation in the renal artery of the rat. J Am Soc Nephrol 1992;2:1291-1297.
24. Bobadilla NA, Tapia E, Franco M, López P, Mendoza S, Gracía-Torres R, Alvarado JA, Herrera-Acosta J: Role of nitric oxide in renal hemodynamic abnormalities of cyclosporine nephrotoxicity. Kidney Int 1994;46:773-779.
25. Dawson TM, Steiner JP, Dawson VL, Dinerman JL, Uhl GR, Snyder SH: Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Proc Natl Acad Sci USA 1993; 90:9808-9812.
26. Schreiber SL: Immunophilin-sensitive protein phosphatase action in cell signaling pathways. Cell 1992;70:365-368.
27. Amore A, Gianoglio B, Ghigo D. Peruzzi L, Porcellini MG, Bussolino F. Costamagna G, Cacace G, Picciotto G, Mazzucco G, Sena LM, Coppo R: A possible role for nitric oxide in modulating the functional cyclosporine toxicity by argmme. Kidnev Int 1995;47:1507-1514.
28. Amal JF, Münzel T, Venema RC, James NL, Bai CL. Mitch WE, Hamson DC: Interactions between L-arginine and L-glutamine change endoihelial NO production: an effect independent of NO synthase substrate availability. J Clin Invest 1995;95:2565-2572.
29. Prashar Y, Khanna A, Sehajpal P, Sharma VK, Suthanthiran M: Stimulation of transforming growth factor-βl transcnption by cyciosporine. FEBS Lett 1995;358:109-112.
30. Mason J, Müller-Schweinitzer E, Dupont M, Casellas D, Mihatsch M, Moore L, Kaskel F: Cyciosporine and the renin-angiotensin system. Kidney Int 1991;39(suppl):28-32.
31. Burdmann EA, Andoh TF, Nast CC, Evan A, Connors BA, Coffman TM, Lmdsley J, Bennett WM: Prevention of experimental cyclosporininduced interstitial fibrosis by losartan and enalapril. Am J Physiol 1995;269:F491-F499.
32. De Nicola L, Blantz RC, Gabbai FB: Nitric oxide and angiotensin II: Glomerular and tubular interaction in the rat. J Clin Invest 1992;89: 1248-1256.
33. Kolpakov V, Gordon D, Kulik TJ: Nitric oxide-generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells. Circ Res 1995;76:305-309.
34. Trachtman H, Futterweit S, Singhal P: Nitric oxide modulates the synthesis of extracellular proteins in cultured rat mesangial cells. Biochem Biophys Res Commun 1995;207:120-125.
35. Qiu C, Engels K, Samsell L, Baylis C: Renal effects of acute ammo acid infusion in hypertension induced by chronic nitric oxide inhibition. Hypertension 1995;25:61-66.
36. Tomohiro A, Kimura S, He H, Fujisawa Y, Nishiyama A, Kiyomoto K, Aki Y, Tamaki T, Abe Y: Regional blood flow in Dahl-Iwai saltsensitive rats and the effects of dietary L-arginine supplementation. Am J Physiol 1997;272: R1013-R1019.
37. Elzinga LW, Rosen S, Bennett WM: Dissociation of glomerular filtration rate from tubulomterstitial fibrosis in experimental chronic cyciosporine nephrotoxicity: Role of sodium intake. J Am Soc Nephrol 1993;4:214-221.
38. Curtis JJ, Luke RG, Jones D, Diethelm AG: Hypertension in cyclosporin-treated renal transplant recipients is sodium dependent. Am J Med 1988;85:134-138.
39. Sanders PW: Salt-sensitive hypertension: Lessons from animal models. Am J Kidney Dis 1996;28:775-782.
40. Scholz H, Kurtz A: Involvement of endothelium-dependent relaxing factor in the pressure control of renin secretion from isolated perfused kidney. J Clin Invest 1993;91:1088-1094.
41. Romero JC, Lahera V, Salmon MG, Biondi ML: Role of endothelium-dependent relaxing factor nitric oxide on renal function. J Am Soc Nephrol 1992;2:1371-1387.
42. Beierwaltes WH, Carretero OA: Nonprostanoid endothebum-derived factors inhibit renin release. Hypertension 1992;19(suppl II):68-73.
43. Vidal MJ, Rornero JC, Vanhoutte PM: Endothelium-derived relaxing factor inhibits renin release, Eur J Pharmacol 1988;149:401-402.
44. Kurtz A, Kaissling B, Busse R, Baier W: Endothelial cells modulate renin secretion for isolated mouse juxtaglomerular cells. J Gin Invest 1991;88-1147-1154.
45. Stricker K, Kurtz A: Blockade of nitric oxide formation inhibits the stimulation of the renin system by a low salt intake. Eur J Physiol 1996; 432:187-191.
46. Gardes J, Poux JM, Gonzalez MF, AlhencGelas F, Menard J: Decreased renin release and constant kallikrein secretion after injection of L-NAME in isolated perfused rat kidney. Life Sci 1992;50:987-993.
47. Baxter CR, Duggin Wilis NS, Hall BM, Horvath JS, Tiller DJ: Cyclosporine A-induced increases in renin storage and release. Res Commun Chem Pathol Pharmacol 1982;37: 305-312.
48. Perico N, Benigni A, Bosco E, Rossini M, Orisio S, Ghilardi F, Piccinelli A, Remuzzi G: Acute cyclosporine A nephrotoxicity in rats: Which role for renin-angiotensm system and glomerular prostaglandins? Clin Nephrol 1986; 25(suppl):83-88.
49. Duggin GG, Baxter C, Hall BM, Horvath JS, Tiller DJ: Influence of cyclosporine A on intrarenal control of GFR. Clin Nephrol 1986; 25(suppl):43-45.
50. Bellet M, Cabrol C, Sassano P, Leger P, Corvol P, Menard J: Systemic hypertension after cardiac transplantation: Effect of cyclosporine on the renin-angiotensm-aldosterone system. Am J Cardiol 1985;56:927-931.
51. Bantle JP, Boudreau RJ, Ferris TF: Suppression of plasma renin activity by cyclosporine. Am J Med 1987;83:59-64.
52. Ingelfinger JR, Pratt RE, Ellison K, Dzau VJ: Sodium regulation of angiotensinogen mRNA expression in rat kidney cortex and medulla. J Clin Invest 1986;78:1311-1315.
53. Samani NJ, Swales JD, Brammar WJ: Expression of the renin gene in extra-renal tissues of the rat, Biochem J 1988;907-910.
54. de Nicola L, Thomson SC, Wead LM, Brown MR, Gabbai FB: Arginine feeding modifies cyclosporine nephrotoxicity in rats. J Clin Invest 1993;92:1859-1865.
55. Wang C, Salahudeen AK: Lipid peroxidation accompanies cyclosporine nephrotoxicity: Effects of vitamin E. Kidney Int 1995;47:927-934.
56. Nath KA, Salahudeen AK: Induction of renal growth and injury in the intact rat kidney by dietary deficiency of antioxidants. J Clin Invest 1991;88:1886-1893.
57. Bijlsma JA, Rabelink AJ, Kaasjager AH, Koomans HA: L-Arginine does not prevent the renal effects of endothelin in humans. J Am Soc Nephrol 1995;5:1508-1516.
58. Gaston RS, Schlessinger SD, Sanders PW, Barkder CV, Curtis JJ, Wamock DG: Cyclosporine inhibits the renal response to L-arginine in human kidney transplant recipients. J Am Soc Nephrol 1995;5:1426-1433.